We have identified subsets of nuclear genes that encode mitochondrial proteins that can either enhance or decrease the impact of PLK1-directed treatments (pharmacological inhibition, gene silencing, gene knockout) on melanoma cell proliferation. The gene discussed is PLK1; the disease is melanoma.